Transforming growth factor-β1 increases bad phosphorylation and protects neurons against damage

被引:223
|
作者
Zhu, Y
Yang, GY
Ahlemeyer, B
Pang, L
Che, XM
Culmsee, C
Klumpp, S
Krieglstein, J
机构
[1] Univ Marburg, Inst Pharmakol & Toxikol, D-35032 Marburg, Germany
[2] Univ Marburg, Inst Pharmazeut Chem, D-35032 Marburg, Germany
[3] Univ Michigan, Dept Surg, Ann Arbor, MI 48109 USA
来源
JOURNAL OF NEUROSCIENCE | 2002年 / 22卷 / 10期
关键词
TGF-beta; 1; neuroprotection; MAPK/Erk signaling; Bad phosphorylation; cerebral ischemia; rat hippocampal cells;
D O I
10.1523/JNEUROSCI.22-10-03898.2002
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Despite the characterization of neuroprotection by transforming growth factor-beta1 (TGF-beta1), the signaling pathway mediating its protective effect is unclear. Bad is a proapoptotic member of the Bcl-2 family and is inactivated on phosphorylation via mitogen-activated protein kinase (MAPK). This study attempted to address whether MAPK signaling and Bad phosphorylation were influenced by TGF-beta1 and, furthermore, whether these two events were involved in the antiapoptotic effect of TGF-beta1. We found a gradual activation of extracellular signal-regulated kinase 1/2 (Erk1/2) and MAPK-activated protein kinase-1 (also called Rsk1) and a concomitant increase in Bad phosphorylation at Ser(112) in mouse brains after adenovirus-mediated TGF-beta1 transduction under nonischemic and ischemic conditions induced by transient middle cerebral artery occlusion. Consistent with these effects, the ischemia-induced increase in Bad protein level and caspase-3 activation were suppressed in TGF-beta1-transduced brain. Consequently, DNA fragmentation, ischemic lesions, and neurological deficiency were significantly reduced. In cultured rat hippocampal cells, TGF-beta1 inhibited the increase in Bad expression caused by staurosporine. TGF-beta1 concentration- and time-dependently activated Erk1/2 and Rsk1 accompanied by an increase in Bad phosphorylation. These effects were blocked by U0126, a mitogen-activated protein kinase/Erk kinase 1/2 inhibitor, suggesting an association between Bad phosphorylation and MAPK activation. Notably, U0126 and a Rsk1 inhibitor (Ro318220) abolished the neuroprotective activity of TGF-beta1 in staurosporine-induced apoptosis, indicating that activation of MAPK is necessary for the antiapoptotic effect of TGF-beta1 in cultured hippocampal cells. Together, we demonstrate that TGF-beta1 suppresses Bad expression under lesion conditions, increases Bad phosphorylation, and activates the MAPK/Erk pathway, which may contribute to its neuroprotective activity.
引用
收藏
页码:3898 / 3909
页数:12
相关论文
共 50 条
  • [21] Curcumin protects against lipopolysaccharide-induced vasoconstriction dysfunction via inhibition of thrombospondin-1 and transforming growth factor-β1
    Lu, Wei
    Jiang, Jian-Ping
    Hu, Jue
    Wang, Jue
    Zheng, Ming-zhi
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2015, 9 (02) : 377 - 383
  • [22] Sirolimus increases transforming growth factor-β1 expression and potentiates chronic cyclosporine nephrotoxicity
    Shihab, FS
    Bennett, WM
    Yi, H
    Choi, SO
    Andoh, TF
    KIDNEY INTERNATIONAL, 2004, 65 (04) : 1262 - 1271
  • [23] Transforming growth factor-β1 increases survival of human melanoma through stroma remodeling
    Berking, C
    Takemoto, R
    Schaider, H
    Showe, L
    Satyamoorthy, K
    Robbins, P
    Herlyn, M
    CANCER RESEARCH, 2001, 61 (22) : 8306 - 8316
  • [24] Moyamoya disease and transforming growth factor-β1
    Ueno, M
    Kira, R
    Matsushima, T
    Inoue, T
    Fukui, M
    Gondo, K
    Ihara, K
    Hara, T
    JOURNAL OF NEUROSURGERY, 2000, 92 (05) : 907 - 908
  • [25] Transforming growth factor-β1 and diabetic nephropathy
    Chang, Albert S.
    Hathaway, Catherine K.
    Smithies, Oliver
    Kakoki, Masao
    AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2016, 310 (08) : F689 - F696
  • [26] Transforming growth factor-β1 in plaque morphea
    Danczak-Pazdrowska, Aleksandra
    Kowalczyk, Michal J.
    Szramka-Pawlak, Beata
    Gornowicz-Porowska, Justyna
    Szewczyk, Aleksandra
    Silny, Wojciech
    Molinska-Glura, Marta
    Olewicz-Gawlik, Anna
    Zaba, Ryszard
    Pazdrowski, Jakub
    Hrycaj, Pawel
    POSTEPY DERMATOLOGII I ALERGOLOGII, 2013, 30 (06): : 337 - 342
  • [27] Transforming Growth Factor-β1 and Regulators of Apoptosis
    Sulkowski, Stanislaw
    Wincewicz, Andrzej
    Sulkowska, Mariola
    Koda, Mariusz
    NATURAL COMPOUNDS AND THEIR ROLE IN APOPTOTIC CELL SIGNALING PATHWAYS, 2009, 1171 : 116 - 123
  • [28] Transforming growth factor-β1 and disorders of the lung
    Camoretti-Mercado, B
    Solway, A
    CELL BIOCHEMISTRY AND BIOPHYSICS, 2005, 43 (01) : 131 - 148
  • [29] Transforming growth factor-β1 in hemangioma of the ovary
    Loverro, G
    Cormio, G
    Perlino, E
    Vicino, M
    Cazzolla, A
    Selvaggi, L
    GYNECOLOGIC AND OBSTETRIC INVESTIGATION, 1998, 46 (03) : 210 - 213
  • [30] Transforming growth factor-β1 and disorders of the lung
    Blanca Camoretti-Mercado
    Julian Solway
    Cell Biochemistry and Biophysics, 2005, 43 : 131 - 148